ArticleJCO clinical cancer informatics2024
Classifying Tumor Reportability Status From Unstructured Electronic Pathology Reports Using Language Models in a Population-Based Cancer Registry Setting.
Article in JCO clinical cancer informatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- AI-Enabled Real-World Evidence in Oncology: A Statistical Perspective for Regulatory Decisions.Therapeutic innovation & regulatory science · 2026Review
- Article
- Large language models for cancer registry abstraction: a real-world evaluation across models, variables, and cancer types.medRxiv : the preprint server for health sciences · 2026Article
- Digital Registrar: A Schema-First Framework for Multi-Cancer Privacy-Preserving Pathology Abstraction via Local LLMs.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposePopulation-based cancer registries (PBCRs) collect data on all new cancer diagnoses in a defined population. Data are sourced from pathology reports, and the PBCRs rely on manual and rule-based solutions. This study presents a state-of-the-art natural language processing (NLP) pipeline, built by fine-tuning pretrained language models (LMs). The pipeline is deployed at the British Columbia Cancer Registry (BCCR) to detect reportable tumors from a population-based feed of electronic pathology.
methodsWe fine-tune two publicly available LMs, GatorTron and BlueBERT, which are pretrained on clinical text. Fine-tuning is done using BCCR's pathology reports. For the final decision making, we combine both models' output using an OR approach. The fine-tuning data set consisted of 40,000 reports from the diagnosis year of 2021, and the test data sets consisted of 10,000 reports from the diagnosis year 2021, 20,000 reports from diagnosis year 2022, and 400 reports from diagnosis year 2023.
resultsThe retrospective evaluation of our proposed approach showed boosted reportable accuracy, maintaining the true reportable threshold of 98%.
conclusionDisadvantages of rule-based NLP in cancer surveillance include manual effort in rule design and sensitivity to language change. Deep learning approaches demonstrate superior performance in classification. PBCRs distinguish reportability status of incoming electronic cancer pathology reports. Deep learning methods provide significant advantages over rule-based NLP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.